Wuxi opens biologics plant with JV partner AstraZeneca in attendance
Wuxi AppTec has opened a biologics manufacturing facility that will play a key role in its recent accord with Anglo-Swedish drugmaker AstraZeneca.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs